August 29, 2025
August 29, 2025
August 29, 2025
August 29, 2025
August 28, 2025
August 27, 2025
I am a Lebanese gastroenterologist, a graduate of Saint Joseph University (Beirut). Over the past few years, my concern has grown steadily as I witness not only statistics but also the faces and stories behind them: patients arriving later, tumors larger, livers more cirrhotic, and opportunities for cure diminished. These are no longer abstract headlines in newspapers; they unfold daily in my clinic and endoscopy suite.
In the past five years at my clinic, the number of colonoscopies detecting high-risk polyps has increased by nearly 30%. The proportion of patients under 50 presenting with alarming symptoms (rectal bleeding, anemia, weight loss) has almost doubled compared to previous years. In hepatology, nearly one-third of new patients now present with metabolic fatty liver disease (NAFLD), many of them already showing significant fibrosis on elastography. These figures may not represent the entire nation, but they mirror a concerning trend shared by many colleagues across Lebanon.
Lebanon is blessed with a rich culinary culture and vibrant social life. Yet this also brings challenges: salty diets, high intake of processed meats, charcoal-grilled foods, along with elevated rates of smoking and alcohol consumption. Helicobacter pylori remains a silent burden, fueling ulcers and gastric cancer risk.
On the liver side, sedentary lifestyles, obesity, and prediabetes/diabetes are fueling NAFLD, compounded by the lingering prevalence of hepatitis B and C. Economic hardship delays screening, meaning diseases are often discovered late. I recall a 52-year-old businessman, outwardly healthy, who postponed colonoscopy for two years. When he finally returned, what could have been a removable precancerous polyp had already invaded deeply, requiring major surgery and chemotherapy.
Fatty liver is not just a liver disease; it is a metabolic alarm bell. Patients with NAFLD face a higher risk of coronary artery disease and stroke. In practice, I often see patients referred for elevated liver enzymes. Ultrasound confirms fatty liver, elastography shows moderate fibrosis, and further evaluation reveals uncontrolled hypertension and dyslipidemia. Early diagnosis in such cases is not only about saving the liver or colon but also about reducing future cardiovascular events.
One of my patients, a 56-year-old schoolteacher, finally agreed to a screening colonoscopy after years of postponement. We found a flat 2.5 cm polyp in the cecum. With ESD, it was completely removed, and pathology revealed high-grade dysplasia – meaning that with just a little more delay, invasive cancer would have been likely. Two months later, he returned with relief on his face: “Doctor, you convinced me that screening is not about finding disease, but about preventing it.”
As a gastroenterologist trained at Saint Joseph University, I believe the future of healthcare in Lebanon depends not only on technology but also on community trust and discipline: seeking care early, screening on schedule, changing lifestyles, and respecting evidence-based recommendations. Gastrointestinal cancers and hepatobiliary diseases are not destiny. With timely diagnosis, appropriate tools, and strong medical expertise, we can shift the curve – from late to early, from helplessness to empowerment.
If you or a loved one are concerned about digestive symptoms or test results, do not hesitate to seek comprehensive evaluation. Every day of delay can be a missed opportunity; every proactive step, however small, may change the course of life.